Inhibrx Biosciences, Inc. (NASDAQ:INBX) Receives Consensus Rating of “Hold” from Brokerages
Shares of Inhibrx Biosciences, Inc. (NASDAQ:INBX – Get Free Report) have earned an average recommendation of “Hold” from the six research firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, three have issued a hold rating, one has issued a buy rating and one has […]
20 Jul 04:15 · The Cerbat Gem